Laminopathies and atherosclerosis - PubMed (original) (raw)
Review
Laminopathies and atherosclerosis
Khalid Z Al-Shali et al. Arterioscler Thromb Vasc Biol. 2004 Sep.
Abstract
Laminopathies are genetic diseases that encompass a wide spectrum of phenotypes with diverse tissue pathologies and result mainly from mutations in the LMNA gene encoding nuclear lamin A/C. Some laminopathies affect the cardiovascular system, and a few (namely, Dunnigan-type familial partial lipodystrophy [FPLD2] and Hutchinson-Gilford progeria syndrome [HGPS]) feature atherosclerosis as a key component. The premature atherosclerosis of FPLD2 is probably related to characteristic proatherogenic metabolic disturbances such as dyslipidemia, hyperinsulinemia, hypertension, and diabetes. In contrast, the premature atherosclerosis of HGPS occurs with less exposure to metabolic proatherogenic traits and probably reflects the generalized process of accelerated aging in HGPS. Although some common polymorphisms of LMNA have been associated with traits related to atherosclerosis, the monogenic diseases FPLD2 and HGPS are more likely to provide clues about new pathways for the general process of atherosclerosis. Dunnigan-type familial partial lipodystrophy and Hutchinson-Gilford progeria syndrome are laminopathies caused by mutation in LMNA that feature atherosclerosis, which is related to proatherogenic metabolic disturbances and to the generalized process of accelerated aging, respectively. These monogenic diseases may provide clues about new pathways for atherogenesis.
Similar articles
- Hutchinson-Gilford progeria syndrome.
Pollex RL, Hegele RA. Pollex RL, et al. Clin Genet. 2004 Nov;66(5):375-81. doi: 10.1111/j.1399-0004.2004.00315.x. Clin Genet. 2004. PMID: 15479179 Review. - [The role of lamins and mutations of LMNA gene in physiological and premature aging].
Sliwińska MA. Sliwińska MA. Postepy Biochem. 2007;53(1):46-52. Postepy Biochem. 2007. PMID: 17718387 Review. Polish. - Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP, Rothman FG, Sedivy JM. Csoka AB, et al. Aging Cell. 2004 Aug;3(4):235-43. doi: 10.1111/j.1474-9728.2004.00105.x. Aging Cell. 2004. PMID: 15268757 - Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
Mazereeuw-Hautier J, Wilson LC, Mohammed S, Smallwood D, Shackleton S, Atherton DJ, Harper JI. Mazereeuw-Hautier J, et al. Br J Dermatol. 2007 Jun;156(6):1308-14. doi: 10.1111/j.1365-2133.2007.07897.x. Epub 2007 Apr 25. Br J Dermatol. 2007. PMID: 17459035 Review. - A progeroid syndrome in mice is caused by defects in A-type lamins.
Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL. Mounkes LC, et al. Nature. 2003 May 15;423(6937):298-301. doi: 10.1038/nature01631. Nature. 2003. PMID: 12748643
Cited by
- A Pair of Sibling Patients With Premature Aging Syndrome of Unknown Etiology.
Iwai K, Okawada M. Iwai K, et al. Cureus. 2024 May 29;16(5):e61300. doi: 10.7759/cureus.61300. eCollection 2024 May. Cureus. 2024. PMID: 38947695 Free PMC article. - Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson-Gilford Progeria.
De Simone L, Chiellino S, Spaziani G, Porcedda G, Calabri GB, Berti S, Favilli S, Stefani L, Santoro G. De Simone L, et al. Children (Basel). 2023 Mar 8;10(3):526. doi: 10.3390/children10030526. Children (Basel). 2023. PMID: 36980084 Free PMC article. - Hepatic transcript signatures predict atherosclerotic lesion burden prior to a 2-year high cholesterol, high fat diet challenge.
Puppala S, Spradling-Reeves KD, Chan J, Birnbaum S, Newman DE, Comuzzie AG, Mahaney MC, VandeBerg JL, Olivier M, Cox LA. Puppala S, et al. PLoS One. 2022 Aug 4;17(8):e0271514. doi: 10.1371/journal.pone.0271514. eCollection 2022. PLoS One. 2022. PMID: 35925965 Free PMC article. - Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
Sayed N, Liu C, Ameen M, Himmati F, Zhang JZ, Khanamiri S, Moonen JR, Wnorowski A, Cheng L, Rhee JW, Gaddam S, Wang KC, Sallam K, Boyd JH, Woo YJ, Rabinovitch M, Wu JC. Sayed N, et al. Sci Transl Med. 2020 Jul 29;12(554):eaax9276. doi: 10.1126/scitranslmed.aax9276. Sci Transl Med. 2020. PMID: 32727917 Free PMC article. - Cerebral Haemorrhage in a Young Patient With Atypical Werner Syndrome Due to Mutations in LMNA.
Yanhua X, Suxian Z. Yanhua X, et al. Front Endocrinol (Lausanne). 2018 Aug 3;9:433. doi: 10.3389/fendo.2018.00433. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30123186 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous